We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.2M
AUM Growth
-$35.7M
Cap. Flow
-$37.4M
Cap. Flow %
-231.14%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
1
Closed
4
Avg Time Held
6.7 quarters
Top 10 Avg Time Held
4.6 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
IMNM icon
Immunome
IMNM
+$902K
2
IBRX icon
ImmunityBio
IBRX
+$4.4K

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.49%
2 Healthcare 28.51%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACWI icon
1
iShares MSCI ACWI ETF
ACWI
$33.2B
$11.6M 71.49%
113,737
-365,199
-76% -$34.9M
2022 Q4
4 quarters
ZNTL icon
2
Zentalis Pharmaceuticals
ZNTL
$239M
$2.84M 17.51%
187,143
– –
2020 Q2
14 quarters
IMNM icon
3
Immunome
IMNM
$2.26B
$1.16M 7.17%
+108,480
New +$902K
2023 Q4
0 quarters
NMTC icon
4
NeuroOne Medical Technologies
NMTC
$9.79M
$287K 1.77%
30,292
– –
2021 Q2
10 quarters
UBX icon
5
DELISTED
Unity Biotechnology
UBX
$239K 1.48%
124,081
– –
2019 Q4
16 quarters
SCLX icon
6
Scilex Holding
SCLX
$19.7M
$86.3K 0.53%
1,209
– –
2023 Q1
3 quarters
IBRX icon
7
ImmunityBio
IBRX
$10.7B
$7.04K 0.04%
+1,403
New +$4.4K
2023 Q4
0 quarters
BSM icon
8
Black Stone Minerals
BSM
$3.16B
– –
-166,147
Closed -$2.86M –
CLPT icon
9
ClearPoint Neuro
CLPT
$311M
– –
-38,114
Closed -$191K –
MIRO
10
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
– –
-191,622
Closed -$251K –
EVLO
11
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
– –
-22,577
Closed -$88.5K –

Similar funds

Mayo Clinic's Q4 2023 Portfolio in Review

As of Q4 2023, Mayo Clinic held 11 positions worth $16.2M, down 69% from $51.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic withdrew a net $37.4M in Q4 2023, closing 4 positions and reducing 1 holding. Its most notable exit was Black Stone Minerals, an estimated $2.86M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 85% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Mayo Clinic opened a new position in Immunome worth $1.16M.

  • Mayo Clinic's largest Q4 2023 buy was Immunome: 108,480 shares worth $1.16M.
  • Mayo Clinic's biggest Q4 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $34.9M.
  • Mayo Clinic fully exited Black Stone Minerals in Q4 2023, selling an estimated $2.86M.
  • Mayo Clinic's ten largest holdings make up 100% of its $16.2M portfolio in Q4 2023.
  • Mayo Clinic opened 2 new positions and closed 4 in Q4 2023.
  • Mayo Clinic's portfolio value fell 69% quarter-over-quarter to $16.2M.

Based on Mayo Clinic's 13F filing for Q4 2023, filed 13 Feb 2024.